Abstract:Background A high model of end-stage liver disease (MELD) score (>30) adversely affects outcomes even if patients receive prompt liver transplantation (LT). Therefore, balanced allocation of donor grafts is indispensable to avoid random combinations of donor and recipient risk factors, which often lead to graft or recipient loss. Predictive models aimed at avoiding donor risk factors in high-MELD score recipients are urgently required to obtain satisfactory outcomes. Method Data of patients with MELD score >30 who underwent LT at three transplantation institutes between 2015 and 2018 were retrospectively reviewed. Early allograft dysfunction (EAD), length of intensive care unit (ICU) stay, and graft loss were recorded. Corresponding independent risk factors were analyzed using stepwise multivariable regression analysis. A prediction model of graft loss was developed, and discrimination and calibration were measured. Results After applying the exclusion criteria, 778 patients were enrolled. The incidence of EAD was 34.8% (271/778). Donor graft macrovesicular steatosis, graft-to-recipient weight ratio (GRWR), warm ischemia time (WIT), cold ischemia time (CIT), and ABO blood incompatibility, together with donor serum albumins, were independent predictors of EAD. The incidence of ICU stay over 10 days was 64.7% (503/778). Donor age, recipient's MELD score, Child score, and CIT were independent predictors of ICU stay. The 3-year graft survival rates (GSRs) in the training and validation cohorts were 64.2 and 59.3%, respectively. The independent predictors of graft loss were recipient's Child score, ABO blood type incompatibility, donor serum total bilirubin over 17.1 μmol/L, and cold CIT. A nomogram based on these variables was internally and externally validated and showed good performance (area under the receiver operating characteristic curve = 70.8 and 66.0%, respectively). For a recipient with a high MELD score, the avoidance of ABO blood type incompatibility and CIT ≥6 h would achieve a 3-year GSR of up to 78.4%, whereas the presence of the aforementioned risk factors would decrease the GSR to 35.4%. Conclusion The long-term prognosis of recipients with MELD scores >30 could be greatly improved by avoiding ABO blood type incompatibility and CIT ≥6 h.

Ultrastructural Changes of Donor Livers in Liver Transplantation Indicate Hepatocytes Injury

Effect of Donor Diabetes on Prognosis of Liver Transplantation in Patients with Acute-Chronic Liver Failure

The Role of Ischemia/Reperfusion Injury in Early Hepatic Allograft Dysfunction

Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review.

Extended criteria donor reconditioning and functional improvement in the viewshed of machine perfusion plus

Assessing Donor Liver Quality and Restoring Graft Function in the Era of Extended Criteria Donors.

Combination of Early Allograft Dysfunction and Protein Expression Patterns Predicts Outcome of Liver Transplantation From Donation After Cardiac Death

Impact of Donor Diabetes Mellitus Status on Liver Transplant Outcomes in Patients with Acute-on-chronic Liver Failure

Protein Profiles of Pretransplant Grafts Predict Early Allograft Dysfunction After Liver Transplantation From Donation After Circulatory Death.

Donation After Cardiac Death Liver Transplantation: Graft Quality Evaluation Based On Pretransplant Liver Biopsy

Impact of Intra-Operative Cholangiography and Parenchymal Resection to Donor Liver Function in Living Donor Liver Transplantation

An integrated proteomics and metabolomics approach to assess graft quality and predict early allograft dysfunction after liver transplantation: a retrospective cohort study

Clinical Analysis of Early Allograft Dysfunction in Patients Receiving Donation after Cardiac Death Liver Transplantation

The Predictive Value of Graft Viability and Bioenergetics Testing Towards the Outcome in Liver Transplantation

Early Allograft Dysfunction after Liver Transplantation with Donation after Cardiac Death Donors

Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation

Can ultrasound elastography assess liver quality in brain-dead donors and predict early allograft dysfunction after transplantation?

Systematic Assessment of Safety Threshold for Donor Age in Cadaveric Liver Transplantation

The Influence of Liver Dysfunction Before Transplantation and During Conditioning Period on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation

The Perioperatively Altered Neutrophil-to-Lymphocyte Ratio Associates with Impaired DNA Damage Response in Liver Transplantation Recipients with Hepatocellular Carcinoma

Metabonomic Profile of Macrosteatotic Allografts for Orthotopic Liver Transplantation in Patients With Initial Poor Function: Mechanistic Investigation and Prognostic Prediction